Medtide Inc. (stock short name: MEDTIDE) announced that its Board of Directors resolved on 30 March 2026 to overhaul the company’s governance framework by amending its Articles of Association and abolishing the Supervisory Committee. The proposed changes respond directly to the amended PRC Company Law, adopted on 29 December 2023 and effective from 1 July 2024, which permits listed companies to replace supervisory committees with audit committees under the board.

Key elements of the proposal include: • Transfer of all supervisory functions and powers to the Board’s Audit Committee, in accordance with the revised Company Law and the China Securities Regulatory Commission’s updated “Guidelines on the Articles of Association of Listed Companies” issued on 28 March 2025. • Strengthened safeguards for minority shareholder rights and clarification of responsibilities for controlling shareholders, directors and senior management. • Consequential updates to align the Articles with current laws and regulations, alongside other internal adjustments.

All incumbent supervisors have submitted resignations and confirmed the absence of any disagreement with the Supervisory Committee or issues requiring shareholder attention.

The amendments require approval by special resolution at Medtide’s forthcoming annual general meeting. A detailed circular outlining the full text of the revised Articles and the rationale for abolishing the Supervisory Committee will be posted on the Hong Kong Stock Exchange’s website (www.hkexnews.hk) and the company’s website (www.medtideinc.com) in due course.

As of the announcement date, Medtide’s Board comprises five executive directors, one non-executive director and three independent non-executive directors.